ynetnewsยท59 event signal
Danger of sudden vision loss: the new FDA warning about GLP-1 weight loss injections
businessGLP
FDA orders new warnings for GLP-1 weight-loss and diabetes drugs over a rare optic nerve condition that can cause permanent vision loss; regulators say the absolute risk is very low and advise patients not to stop treatment without medical guidance
Put this headline into context
Use TradingAgents AI to connect the story to the company's filings, fundamentals, market structure, competing bull and bear arguments, and risk review.
Source: FreeNewsAPIRead at ynetnews
Headlines and excerpts belong to the original publisher. Ticker associations are informational and may be incomplete. Market news is not personalized financial advice.